
<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/joey/Project/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.4.2-SNAPSHOT" ident="GROBID" when="2017-08-10T23:40+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Sequence analysis FRED 2: an immunoinformatics framework for Python</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName>
								<forename type="first">Benjamin</forename>
								<surname>Schubert</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Bioinformatics</orgName>
								<orgName type="institution" key="instit1">University of T€ ubingen</orgName>
								<orgName type="institution" key="instit2">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Applied Bioinformatics</orgName>
								<orgName type="institution">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Mathias</forename>
								<surname>Walzer</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Bioinformatics</orgName>
								<orgName type="institution" key="instit1">University of T€ ubingen</orgName>
								<orgName type="institution" key="instit2">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Applied Bioinformatics</orgName>
								<orgName type="institution">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Hans-Philipp</forename>
								<surname>Brachvogel</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Bioinformatics</orgName>
								<orgName type="institution" key="instit1">University of T€ ubingen</orgName>
								<orgName type="institution" key="instit2">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Andr</forename>
								<surname>As Szolek</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Bioinformatics</orgName>
								<orgName type="institution" key="instit1">University of T€ ubingen</orgName>
								<orgName type="institution" key="instit2">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Applied Bioinformatics</orgName>
								<orgName type="institution">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Christopher</forename>
								<surname>Mohr</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Bioinformatics</orgName>
								<orgName type="institution" key="instit1">University of T€ ubingen</orgName>
								<orgName type="institution" key="instit2">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Applied Bioinformatics</orgName>
								<orgName type="institution">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName>
								<forename type="first">Oliver</forename>
								<surname>Kohlbacher</surname>
							</persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Bioinformatics</orgName>
								<orgName type="institution" key="instit1">University of T€ ubingen</orgName>
								<orgName type="institution" key="instit2">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Applied Bioinformatics</orgName>
								<orgName type="institution">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Quantitative Biology Center</orgName>
								<orgName type="institution">T€ ubingen 72076</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of T€ ubingen</orgName>
								<address>
									<addrLine>T€ ubingen 72076</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Max Planck Institute for Developmental Biology</orgName>
								<address>
									<addrLine>Biomolecular Interactions, T€ ubingen</addrLine>
									<postCode>72076</postCode>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Sequence analysis FRED 2: an immunoinformatics framework for Python</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.1093/bioinformatics/btw113</idno>
					<note type="submission">Received on November 23, 2015; revised on February 2, 2016; accepted on February 23, 2016</note>
					<note>*To whom correspondence should be addressed. Associate Editor: Alfonso Valencia Supplementary information: Supplementary data are available at Bioinformatics online.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>Immunoinformatics approaches are widely used in a variety of applications from basic immunological to applied biomedical research. Complex data integration is inevitable in immuno-logical research and usually requires comprehensive pipelines including multiple tools and data sources. Non-standard input and output formats of immunoinformatics tools make the development of such applications difficult. Here we present FRED 2, an open-source immunoinformatics framework offering easy and unified access to methods for epitope prediction and other immu-noinformatics applications. FRED 2 is implemented in Python and designed to be extendable and flexible to allow rapid prototyping of complex applications. Availability and implementation: FRED 2 is available at http://fred-2</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>The field of immunoinformatics has matured over the last decades. Epitope prediction methods are now widely used and have been successfully applied in many areas from basic immunological to translational research (<ref type="bibr">Boisgu erin et al., 2014;</ref><ref type="bibr" target="#b2">Shukla et al., 2015</ref>). However, these applications often require complex pipelines combining multiple tools, multiple data sources and extensive preand post-processing. Furthermore, many of the HLA epitope prediction tools do not offer a unified interface and output format, which makes it difficult to use prediction methods interchangeably. One way to overcome these problems are web-based workbenches like the ones offered by IEDB (<ref type="bibr" target="#b6">Vita et al., 2015</ref>) or EpiToolKit (<ref type="bibr" target="#b0">Schubert et al., 2015</ref>). But often data volume, speed, or legal restrictions (e.g., concerning data privacy) prevent the use of such applications. Also, web-based workbenches usually provide only limited or delayed integration of novel resources and methods. We therefore developed FRamework for Epitope Detection (FRED 2), an opensource, Python-based framework for computational immunology. FRED 2 is the (completely re-implemented) successor of FRED (<ref type="bibr">Feldhahn et al., 2009</ref>) and provides a unified interface to many prediction tools. We implemented routines covering data pre-processing, HLA typing, epitope prediction, epitope selection, as well as epitope assembly. FRED 2 is flexibly designed to allow easy extension. By building on top of popular modules such as BioPython (http://biopython.org) and Pandas (http://pandas.pydata.org), FRED 2 allows rapid prototyping of complex and innovative immunoinformatics applications.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Implementation</head><p>FRED 2 covers four major areas of immunoinformatics: T-cell epitope prediction, epitope selection, epitope assembly and HLA typing (<ref type="figure" target="#fig_0">Fig. 1</ref>EpitopePrediction, TAPPrediction and CleavagePrediction, each providing factory classes as entry points for the supported prediction methods. A detailed overview of the supported prediction methods can be found in Supplementary Table S1. OptiTope (<ref type="bibr" target="#b4">Toussaint and Kohlbacher, 2009</ref>), a highly flexible mathematical framework capable of expression various aspects of epitope-based vaccines, was implemented for epitope selection. To enable epitope assembly, FRED 2 implements the traveling-salesperson (TSP) approach proposed by<ref type="bibr" target="#b5">Toussaint et al. (Toussaint et al., 2011</ref>) and OptiVac (<ref type="bibr" target="#b1">Schubert and Kohlbacher, 2016</ref>) for stringof-beads design with optimal spacer sequences, which is similar to the approach taken in (<ref type="bibr">Antonets and Bazhan, 2013</ref>). For HLA typing, FRED 2 provides wrapper methods for many HLA typing approaches, such as OptiType (<ref type="bibr" target="#b3">Szolek et al., 2014</ref>), Polysolver (<ref type="bibr" target="#b2">Shukla et al., 2015</ref>), seq2HLA (<ref type="bibr">Boegel et al., 2013</ref>) and ATHLATES (<ref type="bibr">Liu et al., 2013</ref>). FRED 2 also offers methods to interact with many biological databases like BioMart, UniProt, RefSeq and Ensembl. It provides support for handling sequence variations at all major biological levels, from transcript, protein, to peptide level. FRED 2 is open-source software and released under a three-clause BSD license. It was designed to be open and easily extendable by providing self explanatory interfaces so that implementation of new functionalities by a wider community can be easily accomplished.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Applications</head><p>A typical application of immunoinformatics is population-based vaccine design. In the following we show how to perform this task using FRED 2. Given a target population represented by their HLA alleles and virus proteins of interest, OptiTope (<ref type="bibr" target="#b4">Toussaint and Kohlbacher, 2009</ref>) can be used to select the most immunogenic epitopes that are constrained to cover at least a fraction of HLA alleles and antigens. The immunogenicity of the epitopes can be approximated using NetMHC (<ref type="bibr">Lundegaard et al., 2008</ref>) or similar prediction tools supported by FRED 2. All prediction methods can interact with FRED 2s implementation of OptiTope, overcoming previous limitations of the tool (<ref type="bibr" target="#b4">Toussaint and Kohlbacher, 2009</ref>). The described approach and the corresponding FRED 2 implementation can be found in Listing 1.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">Conclusion</head><p>We present FRED 2, a versatile immunoinformatics software framework enabling a unified interface to many tools, from epitope prediction, HLA typing, to epitope selection and assembly. Its openness and easy extensibility makes FRED 2 a perfect instrument for the development of advanced immunoinformatics pipelines that are needed for example in cancer immunotherapy development and other areas of personalized medicine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p>This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 633592 (APERIM). OK acknowledges funding from the Deutsche Forschungsgemeinschaft (SFB685/B1).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Prediction Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epitope Selection</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OptiTope</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HLA Typing</head><p>OptiType Polysolver seq2HLA ATHLATES IO<ref type="figure" target="#fig_0">Fig. 1</ref>Schematic overview of FRED 2. FRED 2 is organized into modules dealing with epitope, cleavage and TAP prediction, HLA typing, epitope selection and assembly. The framework also offers accession to biological databases FRED 2</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Listing1:</head><figDesc>Population-based vaccine design with FRED 2 1. #read in virus proteins of interest 2. prots ¼ IO.read_fasta( " ./proteins.fasta " ,in_type ¼ Protein) 3. #read in HLA alleles of target population 4. hlas ¼ IO.read_line( " ./europe_hlas.txt " ,in_type ¼ Allele) 5. #generate 9mer peptides from proteins 6. peps ¼ Generator.generate_peptides_from_proteins(prots,9) 7. 8. #predict binding affinity 9. netMHC ¼ EpitopePredictionFactory( " NetMHC " ) 10. aff ¼ netMHC.predict(peps, alleles ¼ hlas) 11. #initialize OptiTope and select up to 10 epitopes. 12. #assume a binding threshold of 500nM ¼ 0.425 NetMHC score 13. opt ¼ OptiTope(aff, threshold ¼ {a:0.425 for a in hlas}) 14. opt.set_k(10) 15. opt.activate_antigen_coverage_const(0.8) 16. opt.activate_allele_coverage_const(0.9) 17. selection ¼ opt.solve() Other tutorials in form of IPython notebooks, as well as detailed documentation of the source code can be found on FRED 2's GitHub repository (http://fred-2.github.io).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><figDesc>Conflict of Interest: none declared. References Antonets,D.V. and Bazhan,S.I. (2013) PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens. BMC Res. Notes, 6, 407. Boegel,S. et al. (2013) HLA typing from RNA-Seq sequence reads. Genome Med., 4, 102. Boisgu erin,V. et al. (2014) Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside. Br. J. Cancer, 111, 1469–1475. Feldhahn,M. et al. (2009) FRED—a framework for T-cell epitope detection. Bioinformatics, 25, 2758–2759. Liu,C. et al. (2013) ATHLATES: accurate typing of human leukocyte antigen through exome sequencing. Nucleic Acids Res., 41, e142-e142. Lundegaard,C. et al. (2008) NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11. Nucleic Acids Res., 36, W509–W512.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="false"><figDesc>). Prediction methods are split into three packages V C The Author 2016. Published by Oxford University Press.</figDesc><table></table></figure>

			<note place="foot">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Bioinformatics, 32(13), 2016, 2044–2046 doi: 10.1093/bioinformatics/btw113 Advance Access Publication Date: 26 February 2016 Applications Note at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>

			<note place="foot">at :: on August 30, 2016 http://bioinformatics.oxfordjournals.org/ Downloaded from</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct   xml:id="b0">
	<analytic>
		<title level="a" type="main">EpiToolKit—a web-based workbench for vaccine design</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Schubert</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2211" to="2213" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b1">
	<analytic>
		<title level="a" type="main">Designing string-of-beads vaccines with optimal spacers</title>
		<author>
			<persName>
				<forename type="first">B</forename>
				<surname>Schubert</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">O</forename>
				<surname>Kohlbacher</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b2">
	<analytic>
		<title level="a" type="main">Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes</title>
		<author>
			<persName>
				<forename type="first">S</forename>
				<forename type="middle">A</forename>
				<surname>Shukla</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1152" to="1158" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b3">
	<analytic>
		<title level="a" type="main">OptiType: precision HLA typing from next-generation sequencing data</title>
		<author>
			<persName>
				<forename type="first">A</forename>
				<surname>Szolek</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="3310" to="3316" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b4">
	<analytic>
		<title level="a" type="main">OptiTope—a web server for the selection of an optimal set of peptides for epitope-based vaccines</title>
		<author>
			<persName>
				<forename type="first">N</forename>
				<forename type="middle">C</forename>
				<surname>Toussaint</surname>
			</persName>
		</author>
		<author>
			<persName>
				<forename type="first">O</forename>
				<surname>Kohlbacher</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="617" to="622" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b5">
	<analytic>
		<title level="a" type="main">Universal peptide vaccines – optimal peptide vaccine design based on viral sequence conservation</title>
		<author>
			<persName>
				<forename type="first">N</forename>
				<forename type="middle">C</forename>
				<surname>Toussaint</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="8745" to="8753" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct   xml:id="b6">
	<analytic>
		<title level="a" type="main">The immune epitope database (IEDB) 3.0</title>
		<author>
			<persName>
				<forename type="first">R</forename>
				<surname>Vita</surname>
			</persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="405" to="412" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>